Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Salvage therapy of germ cell tumours.

Literature DB >> 7734312

Salvage therapy of germ cell tumours.

A Horwich.

Abstract

Entities: Disease

Mesh：

Year: 1995 PMID： 7734312 PMCID： PMC2033806 DOI： 10.1038/bjc.1995.175

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

26 in total

1. Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol.

Authors: C R Nichols; S D Williams; P J Loehrer; F A Greco; E D Crawford; J Weetlaufer; M E Miller; A Bartolucci; L Schacter; L H Einhorn
Journal: J Clin Oncol Date: 1991-07 Impact factor: 44.544

2. 21-day cycles of oral etoposide in heavily pretreated metastatic germ-cell cancer.

Authors: B M Cantwell; M J Millward; M J Lind; A H Calvert
Journal: Lancet Date: 1990-10-20 Impact factor: 79.321

3. Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.

Authors: G J Bosl; A Yagoda; R B Golbey; W Whitmore; H Herr; P Sogani; M Morse; N Vogelzang; G MacDonald
Journal: Am J Med Date: 1985-03 Impact factor: 4.965

4. VP16-213 as a single agent in advanced testicular tumors.

Authors: B M Fitzharris; S B Kaye; S Saverymuttu; E S Newlands; A Barrett; M J Peckham; T J McElwain
Journal: Eur J Cancer Date: 1980-09 Impact factor: 9.162

5. Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group.

Authors: J A Levi; D Thomson; V Harvey; G Gill; D Raghavan; M Tattersall; R Snyder; I Burns; T Sandeman; M Byrne
Journal: J Clin Oncol Date: 1990-01 Impact factor: 44.544

6. Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Authors: R J Motzer; N L Geller; C C Tan; H Herr; M Morse; W Fair; J Sheinfeld; P Sogani; P Russo; G J Bosl
Journal: Cancer Date: 1991-03-01 Impact factor: 6.860

7. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Authors: A Harstrick; H J Schmoll; H Wilke; C H Köhne-Wömpner; M Stahl; C Schöber; J Casper; L Bruderek; E Schmoll; C Bokemeyer
Journal: J Clin Oncol Date: 1991-09 Impact factor: 44.544

8. Advanced extragonadal germ-cell tumors. Successful treatment with combination chemotherapy.

Authors: J D Hainsworth; L H Einhorn; S D Williams; M Stewart; F A Greco
Journal: Ann Intern Med Date: 1982-07 Impact factor: 25.391

9. High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated.

Authors: R J Motzer; S C Gulati; J P Crown; S Weisen; M Doherty; H Herr; W Fair; J Sheinfeld; P Sogani; P Russo
Journal: Cancer Date: 1992-01-15 Impact factor: 6.860

10. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

Authors: A H Calvert; D R Newell; L A Gumbrell; S O'Reilly; M Burnell; F E Boxall; Z H Siddik; I R Judson; M E Gore; E Wiltshaw
Journal: J Clin Oncol Date: 1989-11 Impact factor: 44.544

3 in total

Review 1. Regular review: Managing testicular cancer.

Authors: D Dearnaley; R Huddart; A Horwich
Journal: BMJ Date: 2001-06-30

Review 2. Testicular carcinoma.

Authors: A O'Callaghan; G M Mead
Journal: Postgrad Med J Date: 1997-08 Impact factor: 2.401

3. First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).

Authors: Lars Arne Berger; Carsten Bokemeyer; Anja Lorch; Marcus Hentrich; Hans-Georg Kopp; Thomas Christoph Gauler; Jörg Beyer; Maike de Wit; Frank Mayer; Ina Boehlke; Christoph Oing; Friedemann Honecker; Karin Oechsle
Journal: J Cancer Res Clin Oncol Date: 2014-04-03 Impact factor: 4.553

3 in total